You are here

sintilimab

Data and regulatory roundup: Pfizer’s feat, an ADHD miss, Eli Lilly’s CRL & more

MedCity News

Mon, 03/28/22 - 10:17 am

Aligos Therapeutics

Vallon Pharmaceuticals

ORIC Pharmaceuticals

Neurana Pharmaceuticals

In Expected Decision, FDA Rejects Lilly's Sintilimab in NSCLC

BioSpace

Thu, 03/24/22 - 10:58 am

Good news for Lilly as sintilimab hits the spot in lung cancer again

Pharmaforum

Tue, 10/19/21 - 10:47 am

non-squamous non-small cell lung cancer

non-small cell lung cancer

Innovent - Eli Lilly's Sintilimab Combo Shows Sustained Survival Benefit In Lung Cancer Patients

Benzinga

Fri, 08/6/21 - 11:16 am

Innovent Biologics

clinical trials

non-small cell lung cancer

FDA review of Lilly/Innovent’s sintilimab paves way for cut-price immunotherapy option

Pharmaforum

Wed, 05/19/21 - 10:26 am